摘要
目的观察高位结肠透析联合肾康栓保留灌肠治疗慢性肾脏病的疗效。方法将120例慢性肾脏病患者随机分为对照组和治疗组,对照组患者采用结肠透析,治疗组在对照组治疗的基础上联合肾康栓保留灌肠,治疗12次后,比较两组的临床疗效和生化指标改善情况。结果治疗组总有效率为92.5%,对照组总有效率为77.5%,两组比较,差异具有统计学意义(P<0.05),治疗组患者的血肌酐、尿素氮及血尿酸等指标与治疗前相比,改善状况明显优于对照组(P<0.05)。结论慢性肾脏病患者采用结肠透析联合肾康栓保留灌肠治疗,疗效确切,能有效地改善患者症状,减轻或延缓肾功能损害,是CKD患者安全有效的治疗方法,值得在临床上大力推广与应用。
Objective To observe the effect of high-position colon dialysis and Shenkang suppository retention enema in the treatment of CKD. Methods One hundred and twenty cases with CKD in our hospital were selected in this study, and80 patients treated with colon dialysis and retention enema were designed as treatment group and 40 patients treated with colon dialysis were named as control group. After 12 weeks treatment, the clinical effect and biochemical index were compared between the two groups. Results The total effective rate of the treatment group was 92.5% and it was higher than that of the control group of 77.5%（P〈0.05）. The levels of SCr, BUN, UA were decreased significantly in two groups, and treatment group had better effects than control group（P〈0.05）.Conclusion Colon dialysis combined with Shenkang suppository retention enema can improve the clinical symptoms and reduce the impairment of renal function. The combined treatment method has obviously curative effects on CKD patients and it is worthy of clinical promotion.
出处
《临床医学研究与实践》
2016年第15期18-19,29,共3页
Clinical Research and Practice
基金
陕西省科技厅2016年社会发展科技攻关项目"高位结肠透析联合肾康栓保留灌肠对CKD3-4期临床疗效观察及其对血浆PAI-1的影响"(No.2016SF-317)
